Atlas Trials

Asylia Diagnostics BV

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Asylia Diagnostics BV

RecordFirmDate
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors (NCT04860076)Asylia Diagnostics BV2020-06-06

Track Asylia Diagnostics BV automatically

Every clearance here is in the API, with alerts when new ones post.